成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 870-24-6
Chemical Structure| 870-24-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 870-24-6

,{[proInfo.pro_purity]}

4.5 *For research use only!

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

USA Stock *0-1 Day

Global Stock *5-7 Days

 In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online technical Q&A
Product Citations

Alternative Products

Product Details of [ 870-24-6 ]

CAS No. :870-24-6
Formula : C2H7Cl2N
Linear Structure Formula :ClCH2CH2NH2·HCl
M.W : 115.99
MDL No. :MFCD00012887
InChI Key :ONRREFWJTRBDRA-UHFFFAOYSA-N
Pubchem ID :9793737

Safety of [ 870-24-6 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P301+P312-P302+P352-P304+P340-P305+P351+P338

Calculated chemistry of [ 870-24-6 ] Show Less

Physicochemical Properties

Num. heavy atoms 5
Num. arom. heavy atoms 0
Fraction Csp3 1.0
Num. rotatable bonds 1
Num. H-bond acceptors 1.0
Num. H-bond donors 1.0
Molar Refractivity 26.2
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

26.02 ?2

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

0.0
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

0.68
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

0.99
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

0.75
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

0.24
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.53

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-0.92
Solubility 13.9 mg/ml ; 0.12 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-0.8
Solubility 18.2 mg/ml ; 0.157 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-0.83
Solubility 17.3 mg/ml ; 0.149 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

 High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

 Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

 No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

 No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

 No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

 No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

 No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

 No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.52 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

 0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

 None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

 0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

 0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

 3.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

1.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

 No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

 1.52

Application In Synthesis [ 870-24-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 870-24-6 ]
  • Downstream synthetic route of [ 870-24-6 ]

[ 870-24-6 ] Synthesis Path-Upstream   1~1

  • 1
  • [ 870-24-6 ]
  • [ 26364-65-8 ]
YieldReaction ConditionsOperation in experiment
56.9% With sodium hydroxide In water at 70 - 75℃; for 4 h; At first, water (5.Og) and aqueous phase from the methylation (5.Og, which containing approximately 0.0046 moles of the sodium methyl N-cyanodithioiminocarbonate, prepared as in Example 4 above) were taken in a 250 ml round bottom flask. The remaining aqueous phase from the methylation (71 .4g, containing approximately 0.066 moles of the sodium methyl N-cyanodithioiminocarbonate) and 70percent aqueous solution of 2- chloroethylammonium hydrochloride (20.0g, 70percent aqueous solution, 0.12 moles) were mixed in an addition funnel and this mixture was added to the flask over 4 hours at 70 —75°C maintaining the pH of the reaction mixture between 6.3 and 6.8 with concomitant addition of 50percent aqueous NaOH. The rest of the procedure was the same as in Example 4 above. Here, the weight of the dried CIT product was 6.9g with a purity of 97.8percent. The organic impurities as seen on LC were 0.9percent while the rest were inorganic salts, for example, sodium methyl sulfate and sodium chloride. The isolated yield of CIT based on cyanamide was 5 6.9percent.
Reference： [1] Patent: WO2017/48628, 2017, A1, . Location in patent: Paragraph 0082; 0088; 0091; 0092
 

Related Products

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 870-24-6 ]

Aliphatic Chain Hydrocarbons

Chemical Structure| 4535-90-4

A102046[ 4535-90-4 ]

2-Chloro-N-methylethanamine hydrochloride

Similarity: 0.75

Chemical Structure| 821-48-7

A104069[ 821-48-7 ]

Bis(2-Chloroethyl)amine hydrochloride

Similarity: 0.69

Chemical Structure| 10300-69-3

A186338[ 10300-69-3 ]

2-Chloroacetimidamide hydrochloride

Similarity: 0.64

Chemical Structure| 6276-54-6

A257632[ 6276-54-6 ]

3-Chloropropan-1-amine hydrochloride

Similarity: 0.62

Chemical Structure| 124-42-5

A271910[ 124-42-5 ]

Acetamidine hydrochloride

Similarity: 0.58

Chlorides

Chemical Structure| 4535-90-4

A102046[ 4535-90-4 ]

2-Chloro-N-methylethanamine hydrochloride

Similarity: 0.75

Chemical Structure| 821-48-7

A104069[ 821-48-7 ]

Bis(2-Chloroethyl)amine hydrochloride

Similarity: 0.69

Chemical Structure| 10300-69-3

A186338[ 10300-69-3 ]

2-Chloroacetimidamide hydrochloride

Similarity: 0.64

Chemical Structure| 6276-54-6

A257632[ 6276-54-6 ]

3-Chloropropan-1-amine hydrochloride

Similarity: 0.62

Chemical Structure| 79-07-2

A306407[ 79-07-2 ]

2-Chloroacetamide

Similarity: 0.56

Amines

Chemical Structure| 4535-90-4

A102046[ 4535-90-4 ]

2-Chloro-N-methylethanamine hydrochloride

Similarity: 0.75

Chemical Structure| 821-48-7

A104069[ 821-48-7 ]

Bis(2-Chloroethyl)amine hydrochloride

Similarity: 0.69

Chemical Structure| 10300-69-3

A186338[ 10300-69-3 ]

2-Chloroacetimidamide hydrochloride

Similarity: 0.64

Chemical Structure| 6276-54-6

A257632[ 6276-54-6 ]

3-Chloropropan-1-amine hydrochloride

Similarity: 0.62

Chemical Structure| 124-42-5

A271910[ 124-42-5 ]

Acetamidine hydrochloride

Similarity: 0.58